Literature DB >> 15638722

The role of Vpr in HIV-1 pathogenesis.

Joshua L Andersen1, Vicente Planelles.   

Abstract

The HIV-1 vpr gene is conserved among the human (HIV-1, HIV-2) and simian immunodeficiency viruses (SIV). HIV-1 vpr encodes a 96-amino acid, 14 kDa protein (Vpr). Research from a number of laboratories in the last decade has shown that Vpr performs multiple functions, including the induction of cell cycle arrest in the G(2) phase, transactivation of the viral promoter, nuclear import of preintegration complexes, and induction of apoptosis in the infected cell. More recent studies have attempted to elucidate the cellular targets that Vpr utilizes in order to perform the above functions. This review presents the latest findings about the pathogenic events triggered by Vpr, the cellular pathways involved, and the molecular and cellular consequences of the action of Vpr in the context of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15638722     DOI: 10.2174/1570162052772988

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  38 in total

Review 1.  Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation.

Authors:  Jason L Dehart; Vicente Planelles
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

Review 2.  CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection.

Authors:  Yujie Liu; Michael R Nonnemacher; Brian Wigdahl
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

3.  Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of VPR.

Authors:  Eugene Boon Beng Ong; Nobumoto Watanabe; Akiko Saito; Yushi Futamura; Khaled Hussein Abd El Galil; Atsushi Koito; Nazalan Najimudin; Hiroyuki Osada
Journal:  J Biol Chem       Date:  2011-02-28       Impact factor: 5.157

Review 4.  Subversion of Cell Cycle Regulatory Mechanisms by HIV.

Authors:  Andrew P Rice; Jason T Kimata
Journal:  Cell Host Microbe       Date:  2015-06-10       Impact factor: 21.023

5.  Reverse transcription complex: the key player of the early phase of HIV replication.

Authors:  Sergey Iordanskiy; Michael Bukrinsky
Journal:  Future Virol       Date:  2007-01-01       Impact factor: 1.831

Review 6.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

Review 7.  Viral product trafficking to mitochondria, mechanisms and roles in pathogenesis.

Authors:  Chad D Williamson; Roberta L DeBiasi; Anamaris M Colberg-Poley
Journal:  Infect Disord Drug Targets       Date:  2012-02

8.  Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.

Authors:  Narasimhan J Venkatachari; Leah A Walker; Oznur Tastan; Thien Le; Timothy M Dempsey; Yaming Li; Naveena Yanamala; Alagarsamy Srinivasan; Judith Klein-Seetharaman; Ronald C Montelaro; Velpandi Ayyavoo
Journal:  Virol J       Date:  2010-06-07       Impact factor: 4.099

9.  The human immunodeficiency virus type 1 Vpr protein and its carboxy-terminally truncated form induce apoptosis in tumor cells.

Authors:  Mizuho Nonaka; Yoshie Hashimoto; Shin-Nosuke Takeshima; Yoko Aida
Journal:  Cancer Cell Int       Date:  2009-08-12       Impact factor: 5.722

10.  Characterization of the molecular determinants of primary HIV-1 Vpr proteins: impact of the Q65R and R77Q substitutions on Vpr functions.

Authors:  Guillaume Jacquot; Erwann Le Rouzic; Priscilla Maidou-Peindara; Marion Maizy; Jean-Jacques Lefrère; Vincent Daneluzzi; Carlos M R Monteiro-Filho; Duanping Hong; Vicente Planelles; Laurence Morand-Joubert; Serge Benichou
Journal:  PLoS One       Date:  2009-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.